Clinical trials
Phase 3 Scleroderma, Systemic trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
34 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 2 |
| 2003 | 1 |
| 2004 | 1 |
| 2006 | 1 |
| 2008 | 1 |
| 2010 | 1 |
| 2011 | 4 |
| 2012 | 1 |
| 2013 | 2 |
| 2014 | 1 |
| 2015 | 3 |
| 2016 | 1 |
| 2018 | 1 |
| 2019 | 2 |
| 2022 | 3 |
| 2023 | 1 |
| 2025 | 2 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 23 |
| Active, not recruiting | 3 |
| Recruiting | 3 |
| Not yet recruiting | 2 |
| Terminated | 2 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Actelion | 4 |
| Khon Kaen University | 4 |
| Assistance Publique - Hôpitaux de Paris | 2 |
| Boehringer Ingelheim | 2 |
| Federal University of São Paulo | 2 |
| Hoffmann-La Roche | 2 |
| Johns Hopkins University | 2 |
| Allergan | 1 |
| AstraZeneca | 1 |
| Benesis Corporation | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Scleroderma, Systemic | 34 |
| Scleroderma, Diffuse | 13 |
| Raynaud Disease | 5 |
| Lung Diseases, Interstitial | 4 |
| Autoimmune Diseases | 2 |
| Pulmonary Fibrosis | 2 |
| Ulcer | 2 |
| Anorexia | 1 |
| Arthritis | 1 |
| Arthritis, Rheumatoid | 1 |
Trials
Showing 76 to 34 of 34. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.